We are live on ! Find out more
CMRX

Chimerix, Inc.

Delisted

CMRX was delisted on the 17th of April, 2025.

87 hedge funds and large institutions have $83.1M invested in Chimerix, Inc. in 2019 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 31 increasing their positions, 25 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 25

17% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 12

2% more funds holding

Funds holding: 8587 (+2)

50% less capital invested

Capital invested by funds: $168M → $83.1M (-$84.7M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
87
Holders Change
+2
Holders Change %
+2.35%
% of All Funds
1.91%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
14
Increased
31
Reduced
25
Closed
12
Calls
$3K
Puts
Net Calls
+$3K
Net Calls Change
+$28K
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$8.38M +$518K +179,511 +5%
RG
2
Redmile Group
California
$7.6M -$931K -322,593 -9%
Dimensional Fund Advisors
3
Dimensional Fund Advisors
Texas
$6.41M +$44.7K +15,493 +0.6%
Vanguard Group
4
Vanguard Group
Pennsylvania
$5.81M +$1.48M +513,741 +26%
Renaissance Technologies
5
Renaissance Technologies
New York
$5.4M +$1.56M +539,458 +31%
Fidelity Investments
6
Fidelity Investments
Massachusetts
$4.48M +$3.97K +1,375 +0.1%
Morgan Stanley
7
Morgan Stanley
New York
$4.34M -$1.92M -666,353 -26%
RCM
8
RA Capital Management
Massachusetts
$4.19M +$5.15M +1,782,202 New
NLVP
9
New Leaf Venture Partners
New York
$3.17M
Citadel Advisors
10
Citadel Advisors
Florida
$2.68M -$11.7K -4,055 -0.4%
State Street
11
State Street
Massachusetts
$2.52M -$66.7K -23,114 -2%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$1.96M +$106K +36,757 +5%
N
13
Nuveen
North Carolina
$1.96M +$725K +250,990 +43%
D.E. Shaw & Co
14
D.E. Shaw & Co
New York
$1.6M +$454K +157,203 +30%
OAM
15
Oxford Asset Management
United Kingdom
$1.35M -$42.6K -14,750 -2%
Acadian Asset Management
16
Acadian Asset Management
Massachusetts
$1.35M +$49.8K +17,259 +3%
UBS Group
17
UBS Group
Switzerland
$1.34M +$72.4K +25,082 +5%
Northern Trust
18
Northern Trust
Illinois
$1.26M +$87.6K +30,344 +6%
Connor, Clark & Lunn Investment Management (CC&L)
19
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.12M +$91.1K +31,550 +7%
Man Group
20
Man Group
United Kingdom
$1.09M -$1.03M -356,446 -43%
Jacobs Levy Equity Management
21
Jacobs Levy Equity Management
New Jersey
$1.09M +$730K +252,808 +121%
Two Sigma Investments
22
Two Sigma Investments
New York
$999K +$396K +137,030 +48%
Two Sigma Advisers
23
Two Sigma Advisers
New York
$944K +$462K +160,100 +66%
6CM
24
683 Capital Management
New York
$776K
Goldman Sachs
25
Goldman Sachs
New York
$733K +$21.2K +7,332 +2%

CMRX Hedge Fund Activity: Q3 2019 in Review

87 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Chimerix, Inc. (CMRX) for Q3 2019, worth a combined $83.1M — down 50% from $168M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new CMRX positions and 12 closed out — a net gain of 2 holders — while 31 added to existing stakes and 25 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $5.15M. The largest seller was ArrowMark Colorado Holdings, cutting an estimated $11.4M.

  • 87 institutional investors held Chimerix, Inc. (CMRX) as of Q3 2019, up from 85 in Q2 2019.
  • Funds reported $83.1M of Chimerix, Inc. stock for Q3 2019, down 50% quarter-over-quarter.
  • 14 funds opened new Chimerix, Inc. positions in Q3 2019 and 12 closed out, a net change of +2 holders.
  • The largest Chimerix, Inc. buyer in Q3 2019 was RA Capital Management, an estimated $5.15M added.
  • The largest Chimerix, Inc. seller in Q3 2019 was ArrowMark Colorado Holdings, an estimated $11.4M sold.

Based on aggregated 13F filings for Q3 2019.